Distant metastases from invasive lobular breast carcinoma classic type - treatment and prognosis

Introduction: Invasive lobular carcinoma (ILC) comprises 4-15% of all malignant neoplasms of the breast. The "classical variant of ILC" (C-ILC) constitutes some 60-80% of this cancer. The main cause of treatment failures is dissemination observed in 8-38% patients The disant metastases (DM) are frequently localized in: bones, gastrointestinal tract, uterus, leptomeninges, and ovaries. The aim of this study was to present the methods and results of the treatment of patients with DM from the classical variant of ILC (C-ILC) at a single institution in Poland. Materials and Methods: Between January 1983 and December 2004, 210 women with C-ILC of the breast were primarily treated surgically (mastectomy in 182 (86.7%) patients and breast conserving therapy in 28 (13.3%) patients). Then adjuvant therapy (radiotherapy, chemotherapy, and hormonotherapy) was applied according to presence of clinical indications. Results: The present study focused on a group of 41 patients with a median age of 59 that died with DM from C-ILC during the ten-year follow-up. This failure developed on average 65 months (3-186) after surgery of ILC. The most frequently DM developed: bones (39.1%), GI (small bowell, stomach, colon, rectum) – 31.8%, and reproductive organs (ovary, uterus) – 19.1%. In therapy of DM, different configuration surgery, radiotherapy, and chemo-hormonotherapy were used. The median survival after the diagnosis of DM was connected with localization of distant metastases. Conclusion: Patients with classic variant of infiltrate lobular cancer of breast should be regularly follow-up, which could permit early diagnosis of distant metastases and improve treatment results.

Lobular breast cancer; Distant metastases; Breast cancer.

[1] Arrangoiz R., Papavasiliou P., Dushkin H., Farma J.M.: “Case report and literature review: Metastatic lobular carcinoma of the breast an unusual presentation”. Int. J. Surg. Case Rep., 2011, 2, 301.

[2] Sobinsky J.D., Willson T.D., Podbielski F.J., Connolly M.M.: “Unusual metastatic patterns of invasive lobular carcinoma of the breast”. Case Rep. Oncol. Med., 2013, 2013, 986517

[3] Biglia N., Maggiorotto F., Liberale V., Bounous V.E., Sgro L.G., Pecchio S., et al.: “Clinical-pathologic features, long term-outcome and surgical treatment in a large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC)”. Eur. J. Surg. Oncol., 2013, 39, 455.

[4] Sastre-Garau X., Jouve M., Asselain B., Vincent-Salomon A., Beuzeboc P., Dorval T., et al.: “Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns”. Cancer, 1996, 77, 113.

[5] Brouckaert O., Laenen A., Smeets A., Christiaens M.R., Vergote I., Wildiers H., et al.: “Prognostic implications of lobular breast cancer histology: new insights from a single hospital cross-sectional study and SEER data”. Breast, 2014, 23, 371.

[6] Moran M.S., Yang Q., Haffty B.G.: “The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expression of COX-2, Bcl-2, and p53 as a function of histology”. Breast J., 2009, 15, 571.

[7] Iorfida M., Maiorano E., Orvieto E., Maisonneuve P., Bottiglieri L., Rotmensz N., et al.: “Invasive lobular breast cancer: subtypes and outcome”. Breast Cancer Res. Treat., 2012, 133, 713.

[8] DiCostanzo D., Rosen P.P., Gareen I., Franklin S., Lesser M.: “Prognosisin infiltrating lobular carcinoma. An analysis of "cl assical" and variant tumors”. Am. J. Surg. Pathol., 1990, 14, 12.

[9] Metzger-Filho O., Procter M., de Azambuja E., Leyland- Jones B.,Gelber R.D., Dowsett M., et al.: “Magnitude of trastuzumab benefit in patients with HER2-positive, invasive lobular breast carcinoma: results from the HERA trial”. J. Clin. Oncol., 2013, 31, 1954.

[10] Cristofanilli M., Gonzalez-Angulo A., Sneige N., Kau S.W., Broglio K., Theriault R.L., et al.: “Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes”. J. Clin. Oncol., 2005, 23, 41.

[11] Fortunato L., Mascaro A., Poccia I., Andrich R., Amini M., Costarelli L., et al.: “Lobular breast cancer: same survival and local control compared with ductal cancer, but should both be treated the same way? analysis of an institutional database over a 10-year period”. Ann. Surg. Oncol., 2012, 19, 1107.

[12] Rakha E.A., El-Sayed M.E., Powe D.G., Green A.R., Habashy H., Grainge M.J., et al.: “Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes”. Eur. J. Cancer, 2008, 44, 73.

[13] Pestalozzi B.C., Zahrieh D., Mallon E., Gusterson B.A., Price K.N., Gelber R.D., et al.: “Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials”. J. Clin. Oncol., 2008, 26, 3006.

[14] Saranovic D., Kovac J.D., Knezevic S., Susnjar S., Stefanovic A.D., Saranovic D.S., et al.: “Invasive lobular breast cancer presenting anunusual metastatic pattern in the form of peritoneal and rectal metastases: a case report”. J. Breast Cancer, 2011, 14, 247.

[15] Pestalozzi B.C.: “Brain metastases and subtypes of breast cancer”. Ann. Oncol., 2009, 20, 803.

[16] Arpino G., Bardou V.J., Clark G.M., and Elledge R.M.: “Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome”. Breast Cancer Res., 2004, 63, 149.

[17] Mallon E., Varga Z.: “Relapse of invasive lobular carcinoma”. Breast Dis., 2008-2009, 30, 53.

[18] Bamias A., Baltayiannis G., Kamina S., Fatouros M., Lymperopoulos E., Agnanti N., et al.: “Rectal metastases from lobular carcinoma of the breast: report of a case and literature review”. Ann. Oncol., 2001, 12, 715.

[19] Tuthill M., Pell R., Guiliani R., Lim A., Gudi M., Contractor K.B., et al.: “Peritoneal disease in breast cancer: a specific entity with an extremely poor prognosis”. Eur. J. Cancer, 2009, 45, 2146.

[20] Nihon-Yanagi Y., Park Y., Ooshiro M., Aoki H., Suzuki Y., Hiruta N., et al.: “A case of recurrent invasive lobular carcinoma of the breast found as metastasis to the duodenum”. Breast Cancer, 2009, 16, 83.

[21] Puglisi M., Varaldo E., Assalino M., Ansaldo G., Torre G., Borgonovo G.: “Anal metastasis from recurrent breast lobular carcinoma: a case report”. World J. Gastroenterol., 2009, 15, 1388.

[22] Dedes K.J., Fink D.: “Clinical presentation and surgical management of invasive lobular carcinoma of the breast”. Breast Dis., 2008-2009; 30, 31.

[23] Eljabu W., Finch G., Nottingham J., Vaingankar N.: “Metastatic deposits of breast lobular carcinoma to small bowel and rectum”. Int. J. Breast Cancer, 2011, 2011, 413949.

[24] Mistrangelo M., Cassoni P., Mistrangelo M., Castellano I., Codognotto E., Sapino A., et al.: “Obstructive colon metastases from lobular breast cancer: report of a case and review of the literature”. Tumori, 2011, 97, 800.

[25] Basu S., Last A., Shinkfield M.: “Invasive lobular carcinoma of the breast presenting successively with colonic and gastric metastases”. Int. J. Clin. Pract., 2002, 56, 623.

[26] Kouvaris J.R., Gkongkou P.V., Papadimitriou C.A., Papacharalampous X.N., Antypas C.E., Balafouta M.J., Vlahos L.J.: “Bilateral metastases to extraocular muscles from lobular breast carcinoma”. Onkologie, 2008, 31, 387.

[27] Harris M., Howell A., Chrissohou M., Swindell R.I., Hudson M., Sellwood R.A.: “A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast”. Br. J. Cancer, 1984, 50, 23.

[28] Lamovec J., Bracko M.: “Metastatic pattern of infiltrating lobular carcinoma of the breast: an autopsy study”. J. Surg. Oncol., 1991, 48, 28.

[29] Borst M.J., Ingold J.A.: “Metastatic patterns of invasive lobularversus invasive ductal carcinoma of the breast”. Surgery, 1993, 114, 637.

[30] Dixon A.R., Ellis I.O., Elston C.W., Blamey R.W.: “A comparison of the clinical metastatic patterns of invasive lobular and ductal carcinomas of the breast”. Br. J. Cancer, 1991, 63, 634.

[31] Smith D.B., Howell A., Harris M., Bramwell V.H., Sellwood R.A.: “Carcinomatous meningitis associated with infiltrating lobular carcinoma of the breast”. Eur. J. Surg. Oncol., 1985, 11, 33.

[32] Lamovec J., Zidar A.: “Association of leptomeningeal carcinomatosis in carcinoma of the breast with infiltrating lobular carcinoma. An autopsy study”. Arch. Pathol. Lab. Med., 1991, 115, 507.

[33] Winston C.B., Hadar O., Teitcher J.B., Caravelli J.F., Sklarin N.T., Panicek D.M., Liberman L.: “Metastatic lobular carcinoma of the breast: patterns of spread in the chest, abdomen, and pelvis on CT”. AJR Am. J. Roentgenol., 2000, 175, 795.

[34] Aurello P, D'Angelo F, Cosenza G, Petrocca S, Stoppacciaro A, Ramacciato G, Ziparo V. Gastric metastasis 14 years after mastectomy for breast lobular carcinoma: case report and literature review. Am Surg. 2006; 72: 456.

[35] Ayantunde A.A., Agrawal A., Parsons S.L., Welch N.T.: “Esophagogastric cancers secondary to a breast primary tumor do not require resection”. World J. Surg., 2007, 31, 1597.

[36] Battifora H.: “Metastatic breast carcinoma to the stomach simulating linitis plastica”. Appl. Immunohistochem., 1994, 2, 225.

[37] Cormier W.J., Gaffey T.A., Welch J.M., Welch J.S., Edmonson J.H.: “Linitis plastica caused by metastatic lobular carcinoma of the breast”. Mayo Clin. Proc., 1980, 55, 747.

[38] Vennapusa B., Oman S.A., Parasher G., Cerilli L.A.: “C-kitpositive gastric metastasis of lobular carcinoma of the breast masquerading as gastrointestinal stromal tumor”. Breast Cancer, 2010, 17, 303.

[39] López Deogracias M., Flores Jaime L., Arias-Camisón I., Zamacola I., Murillo Guibert J., Suescun García R., et al.: “Rectal metastasis from lobular breast carcinoma 15 years after primary diagnosis”. Clin. Transl. Oncol., 2010, 12, 150.

[40] Kumar N.B., Hart W.R.: “Metastases to the uterine corpus from extragenital cancers. A clinicopathologic study of 63 cases”. Cancer, 1982, 50, 2163.

[41] Jayson G.C., Howell A., Harris M., Morgenstern G., Chang J., Ryder W.D.: “Carcinomatous meningitis in patients with breast cancer. An aggressive disease variant”. Cancer, 1994, 74, 3135.

[42] Lyda M.H., Tetef M., Carter N.H., Ikle D., Weiss L.M., Arber D.A.: “Keratin immunohistochemistry detects clinically significant metastases in bone marrow biopsy specimens in women with lobular breast carcinoma”. Am. J. Surg. Pathol., 2000, 24, 1593.

[43] Zhao R., Li Y., Yu X., Yang W., Guo X.: “Duodenal metastasis from recurrent invasive lobular carcinoma of breast: a case report and literature review”. Int. J. Clin. Oncol., 2012, 17, 160.

[44] Wolstencroft S.J., Hodder S.C., Askill C.F., Sugar A.W., Jones E.W., Griffiths A.P.: “Orbital metastasis due to interval lobular carcinoma of the breast: a potential mimic of lymphoma”. Arch. Ophthalmol., 1999, 117, 1419.

[45] Nicol K.K., Iskandar S.S.: “Lobular carcinoma of the breast metastatic to the oral cavity mimicking polymorphous low-grade adenocarcinoma of the minor salivary glands”. Arch. Pathol. Lab. Med., 2000, 124, 157.

[46] Papaioannou N., Zervoudis S., Grammatikakis I., Peitsidis P., Palvakis K., Youssef T.F.: “Metastatic lobular carcinoma of the breast t the vulva: a case report and review of the literature”. J. Egypt. Natl. Canc. Inst., 2010, 22, 57.